Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

ASH 2018 /
Developments in CAR T treatments for adult patients

1st - 4th Dec 2018

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 03.12.18
Views: 143
Rating:

Dr David Miklos - Stanford University, Palo Alto, USA

Dr David Miklos speaks to ecancer at ASH 2018 about three different presentations cancer cell therapy in the CAR T arena in adults.

He outlines some of the methods, results and next steps for these studies, as well as potential implications for patients - all within a bigger framework of CAR T research.

Dr Miklos concludes there needs to be a national discussion about cost issues in order to reach more patients with these treatments. 
 

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation